Loss-of-function mutations in ATP13A2/PARK9 cause Kufor–Rakeb syndrome (KRS), a disorder characterized by juvenile-onset parkinsonism and cognitive decline [119]. Here, ATP13A2 is linked to Kufor-Rakeb syndrome.